# Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

> **NCT01912560** · PHASE2 · COMPLETED · sponsor: **Catabasis Pharmaceuticals** · enrollment: 99 (actual)

## Conditions studied

- Dyslipidemia
- Hypercholesterolemia
- Hypertriglyceridemia

## Interventions

- **DRUG:** CAT-2003
- **DRUG:** Placebo
- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT01912560
- **Lead sponsor:** Catabasis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912560, "Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01912560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*